BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38291241)

  • 1. Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma.
    Huang Q; Chen H; Yin D; Wang J; Wang S; Yang F; Li J; Mu T; Li J; Zhao J; Yin R; Li W; Qiu M; Zhang E; Li X
    NPJ Precis Oncol; 2024 Jan; 8(1):24. PubMed ID: 38291241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
    Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F
    Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
    Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
    Liu B; Li X; Li C; Xu R; Sun X
    Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significances of PLOD2, epithelial-mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma.
    Gong X; Wang A; Song W
    Medicine (Baltimore); 2022 Aug; 101(34):e30112. PubMed ID: 36042592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
    J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma.
    Guo D; Sheng K; Zhang Q; Li P; Sun H; Wang Y; Lyu X; Jia Y; Wang C; Wu J; Zhang X; Wang D; Sun Y; Huang S; Yu J; Zhang J
    Cancer Lett; 2024 Apr; 587():216723. PubMed ID: 38342234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma.
    Xie Y; Zhang Z; Lai D; Liang J; Zhao Z; Lu W; Ke J; Lin W; He H
    J Gastrointest Oncol; 2023 Dec; 14(6):2293-2308. PubMed ID: 38196547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glioma-associated oncogene homolog 1 promotes epithelial--mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail.
    Min S; Xiaoyan X; Fanghui P; Yamei W; Xiaoli Y; Feng W
    Cancer Gene Ther; 2013 Jul; 20(7):379-85. PubMed ID: 23788111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.
    Zhang J; Zhu J; Yang L; Guan C; Ni R; Wang Y; Ji L; Tian Y
    Tumour Biol; 2015 Sep; 36(9):6701-14. PubMed ID: 25820824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
    Gao Y; Xuan XY; Zhang HY; Wang F; Zeng QR; Wang ZQ; Li SS
    Cell Biol Int; 2012 Jun; 36(6):571-7. PubMed ID: 22360285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
    Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
    J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA VESTAR Regulates Lymphangiogenesis and Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma by Enhancing VEGFC mRNA Stability.
    Wang Y; Zhang W; Liu W; Huang L; Wang Y; Li D; Wang G; Zhao Z; Chi X; Xue Y; Song Y; Liu X; Zhan Q
    Cancer Res; 2021 Jun; 81(12):3187-3199. PubMed ID: 33771898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystathionine-β-synthase (CBS)/H2S system promotes lymph node metastasis of esophageal squamous cell carcinoma (ESCC) by activating SIRT1.
    Liu Y; Pan L; Li Y; Deng Y; Han X; Fu H; Wang T
    Carcinogenesis; 2022 May; 43(4):382-392. PubMed ID: 34994384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
    Liu H; Zhen Q; Fan Y
    Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum level of lncRNA TUSC7 in patients with esophageal squamous cell carcinoma and its role in promoting tumor cell migration and invasion].
    Zhao K; Guo Y; Huo Z; Ma G; Zhang G; Xing Y; Xu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):661-669. PubMed ID: 32897196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
    Chen Z; Zhao M; Liang J; Hu Z; Huang Y; Li M; Pang Y; Lu T; Sui Q; Zhan C; Lin M; Guo W; Wang Q; Tan L
    EBioMedicine; 2021 Jul; 69():103459. PubMed ID: 34192657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.